HYQVIA is indicated for the treatment of primary immunodeficiency (PI) in adults. HYQVIA is for subcutaneous use only. Safety and efficacy of chronic use of Recombinant Human Hyaluronidase in HYQVIA have not been established in conditions other than PI.

Starting patients

Monthly* SCIG infusions.1
A wide range of support.

*Every 3 or 4 weeks.

Comprehensive support to help patients get started.

Find the resources and support needed to get your adult patients with PI started on HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase].

HYQVIA
start form

Fill out and submit this form to initiate your patient’s HYQVIA treatment.

Download form

Specialty pharmacy
provider list

Find out which specialty pharmacy providers are authorized to dispense HYQVIA.

Identify pharmacies

HYQVIA resources and support programs

Help your patients get the support they need to take HYQVIA as you prescribed.

Learn how
Reference:
  1. HYQVIA [prescribing information]. Lexington, MA: Baxalta US Inc.